Lifecore Biomedical, Inc. - Common Stock (NQ: LFCR )

4.720 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	4.720
Bid (Size)	1.890 (2)
Ask (Size)	5.380 (50)
Prev. Close	4.720
Today's Range	4.720 - 4.720
52wk Range	4.470 - 11.46
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lifecore Biomedical Announces Cooperation Agreement with 22NW

July 01, 2024

Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 22, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Performance

YTD	-26.02%	-26.02%
1 Month	-18.76%	-18.76%
3 Month	-14.49%	-14.49%
6 Month	-26.02%	-26.02%
1 Year	-51.59%	-51.59%

More News

Lifecore Biomedical Completes Incremental Liquidity Initiatives

May 16, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 14, 2024

Via TheNewswire.com

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 14, 2024

Via NewMediaWire

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 10, 2024

Via NewMediaWire

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 10, 2024

Via TheNewswire.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 08, 2024

Via NewMediaWire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 08, 2024

Via TheNewswire.com

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

May 07, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 03, 2024

Via NewMediaWire

ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 03, 2024

Via TheNewswire.com

ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 30, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 29, 2024

Via NewMediaWire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 29, 2024

Via TheNewswire.com

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 26, 2024

Via NewMediaWire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 26, 2024

Via TheNewswire.com

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 25, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 23, 2024

Via NewMediaWire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 23, 2024

Via TheNewswire.com

ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 21, 2024

Via NewMediaWire

ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

April 21, 2024

Via TheNewswire.com

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 20, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report

April 19, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC

April 15, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.